メンタルヘルススクリーニング市場 : 2029年までの世界予測

Report Overview

The Mental Health Screening market is projected to reach USD 1.8 billion by 2029 from USD 0.9 billion in 2023, at a CAGR 12.2% during the forecast period.

メンタルヘルススクリーニング市場は、予測期間中のCAGR 12.2%で、2023年の9億米ドルから2029年までに18億米ドルに達すると予測されています。

The rising awareness of mental health issues due to the growing geriatric population and subsequent increase in prevalence of mental disorders, and increasing focus on remote monitoring are the factors that will drive the growth of this market.  On the other hand, stigma and limited awareness, and data privacy concerns may impede the adoption of mental health screening solutions to a certain extent over the forecast period. 

“AI-based Screening Tools is expected to register highest growth in the forecast period, by technology segment.”
Based on technology, the Mental Health Screening market is segmented into self-screening mHealth apps, telehealth & virtual care solutions, continuous monitoring wearable devices, AI-based screening tools, and remote mental health platforms. The AI-based screening tools segment is projected to witness the highest growth rate during the forecast period. Growth in this market can be attributed to the increasing demand for scalable and accurate solutions in mental health screening, coupled with advancements in AI technology.

“Clinical settings segment is estimated to hold the largest share of Mental Health Screening market, by setting.”
Based on setting, the global mental health screening market is segmented into clinical settings, educational institutions, workplace/corporate programs, online platforms, and other settings. The clinical settings segment accounted for the largest share of the mental health screening market in 2022. This segment is expected to witness significant growth due to increased awareness, the rising prevalence of mental health disorders, technological advancements, policy support, and a shift towards preventive and patient-centered care.

“The Seniors (age 65 and above) segment is expected to register highest growth in the forecast period, by age-group.”
Based on age group, the mental health screening market is segmented into children & adolescents (age 0–18 years), adults (age 19–64 years), and seniors (age 65 and above). The seniors segment is projected to witness the highest growth rate during the forecast period. The growth of mental health screening solutions adoption among seniors is driven by the rising geriatric population and the subsequent increase in age-related conditions like dementia, Alzheimer’s disease, and late-life depression.

“Asia Pacific to register the highest growth in the Mental Health Screening market in the forecast period.”
The global Mental Health Screening market is segmented into four major regions, namely, North America, Europe, APAC, and the Rest of the World. In 2022, Asia Pacific was expected to register the highest growth for Mental Health Screening solutions in the forecast period. Factors such as increasing patient burden, improved accessibility of mental health services due to the growing incidence of mental disorders, and rising government initiatives for increasing awareness about mental disorders are expected to drive the growth of the Mental Health Screening market in the Asia Pacific.

Breakdown of the supply-side, demand side, primary interviews by company type, designation, and region:
•     By Supply Side: Tier 1 (25%), Tier 2 (5%), and Tier 3 (70%)
•     By Designation: C-level Executives (27%), Director-level (18%), and Managers (55%)
•     By Region: North America (45%), Europe (30%), Asia Pacific (20%), Latin America (3%), and Middle East and Africa (2%)

The prominent players in mental health screening market are Adaptive Testing Technologies (US), Proem Behavioral Health (US), Aiberry (US), SonderMind Inc. (US), Clarigent Health (US), Riverside Community Care (US), Kintsugi Mindful Wellness, Inc. (US), Thymia Limited (UK), Ellipsis Health Inc. (US), Canary Speech, Inc. (US), Headspace Health (US), Quartet Health, Inc. (US), Modern Life, Inc. (US), Sonde Health, Inc. (US), FuturesTHRIVE (US), Koninklijke Philips N.V. (Netherlands), Alphabet Inc. (Fitbit) (US), ResMed (US), Apple Inc. (US), MoodFit (US), Wellin5 USA Inc. (Canada), MoodTools (US), Cognitive Health Solutions LLC (US), Woebot Labs Inc. (US), and CogniABle (India). Players adopted organic as well as inorganic growth strategies such as partnerships, acquisitions, and product launches to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage
• The report studies the Mental Health Screening market based on application, screening method, technology, age group, setting, and region. 
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total Mental Health Screening market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
n Analysis of key drivers (growing geriatric population and subsequent increase in prevalence of mental disorders, rising awareness of mental health issues, technological advancements, increasing focus on remote monitoring), restraints (stigma and limited awareness, and Data privacy concerns), opportunities (integration with wearable technologies, and rise of social media and its impact on adoption of mental health screening tools) and challenge (Integration with wearable technologies).
n Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the Mental Health Screening market.
n Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of Mental Health Screening solutions across regions.
n Market Diversification: Exhaustive information about solutions, untapped regions, recent developments, and investments in the Mental Health Screening market.
n Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the Mental Health Screening market.

Table of Contents

1            INTRODUCTION            71

1.1         STUDY OBJECTIVES      71

1.2         MARKET DEFINITION   71

1.2.1      INCLUSIONS & EXCLUSIONS     72

1.3         MARKET SCOPE             73

1.3.1      MARKET SEGMENTATION         73

FIGURE 1           MENTAL HEALTH SCREENING MARKET SEGMENTATION              73

1.3.2      REGIONAL SEGMENTATION     74

FIGURE 2           MENTAL HEALTH SCREENING MARKET: REGIONAL SEGMENTATION           74

1.3.3      YEARS CONSIDERED     74

1.4         STAKEHOLDERS            75

1.5         CURRENCY CONSIDERED          75

2            RESEARCH METHODOLOGY     76

2.1         RESEARCH DATA           76

2.2         RESEARCH APPROACH 76

FIGURE 3           RESEARCH APPROACH 76

2.2.1      SECONDARY DATA       77

2.2.1.1   Key data from secondary sources     77

2.2.2      PRIMARY DATA 78

FIGURE 4           PRIMARY SOURCES       78

2.2.2.1   Key data from primary sources         79

2.2.2.2   Key industry insights          80

2.2.2.3   Breakdown of primaries     80

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    80

2.3         MARKET SIZE ESTIMATION       81

FIGURE 6           MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS              81

FIGURE 7           MENTAL HEALTH SCREENING MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION FOR KONINKLIJKE PHILIPS   82

FIGURE 8           CAGR PROJECTIONS     84

FIGURE 9           IMPACT ON MARKET GROWTH AND CAGR: ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2029)              85

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    86

FIGURE 10         DATA TRIANGULATION METHODOLOGY         86

2.5         MARKET SHARE ESTIMATION   87

2.6         STUDY ASSUMPTIONS  87

2.7         LIMITATIONS   87

2.7.1      METHODOLOGY-RELATED LIMITATIONS         87

2.7.2      SCOPE-RELATED LIMITATIONS             88

2.8         RISK ASSESSMENT         88

TABLE 1             RISK ASSESSMENT: MENTAL HEALTH SCREENING MARKET              88

2.9         IMPACT OF RECESSION ON MENTAL HEALTH SCREENING MARKET              88

3            EXECUTIVE SUMMARY 89

FIGURE 11         MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2023 VS. 2029 (USD MILLION)     89

FIGURE 12         MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2023 VS. 2029 (USD MILLION) 90

FIGURE 13         MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)     90

FIGURE 14         MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2023 VS. 2029 (USD MILLION)             91

FIGURE 15         MENTAL HEALTH SCREENING MARKET, BY SETTING, 2023 VS. 2029 (USD MILLION)     92

FIGURE 16         GEOGRAPHICAL SNAPSHOT OF MENTAL HEALTH SCREENING MARKET            93

4            PREMIUM INSIGHTS      94

4.1         MENTAL HEALTH SCREENING MARKET OVERVIEW       94

FIGURE 17         GROWING INCIDENCE OF MENTAL HEALTH DISORDERS TO DRIVE MARKET 94

4.2         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION AND COUNTRY (2022)    95

FIGURE 18         PHYSIOLOGICAL DISORDERS ACCOUNTED FOR LARGEST SHARE OF MENTAL HEALTH SCREENING MARKET IN 2022         95

4.3         MENTAL HEALTH SCREENING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           96

FIGURE 19         CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       96

4.4         MENTAL HEALTH SCREENING MARKET, BY REGION (2020−2027)              97

FIGURE 20         NORTH AMERICA TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD     97

4.5         MENTAL HEALTH SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES     97

FIGURE 21         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD       97

5            MARKET OVERVIEW     98

5.1         INTRODUCTION            98

5.2         MARKET DYNAMICS     98

FIGURE 22         MENTAL HEALTH SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       98

5.2.1      DRIVERS            99

5.2.1.1   Growing geriatric population and subsequent increase in prevalence of mental disorders              99

5.2.1.2   Rising awareness of mental health issues        99

5.2.1.3   Technological advancements           100

5.2.1.4   Increasing focus on remote monitoring          101

5.2.2      RESTRAINTS     101

5.2.2.1   Stigma and limited awareness          101

5.2.2.2   Data privacy concerns        102

5.2.3      OPPORTUNITIES           103

5.2.3.1   Integration with wearable technologies          103

5.2.3.2   Rise of social media and its impact on adoption of mental health screening tools              103

5.2.4      CHALLENGES   104

5.2.4.1   Concerns regarding accuracy and validity      104

5.3         KEY INDUSTRY TRENDS             104

5.3.1      INTEGRATION WITH PRIMARY CARE SETTINGS             104

5.3.2      DIGITAL AND REMOTE SOLUTIONS      105

5.4         PRICING ANALYSIS        106

TABLE 2             AVERAGE SELLING PRICE TREND, BY REGION  106

TABLE 3             AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY 106

5.5         VALUE/SUPPLY CHAIN ANALYSIS          107

5.5.1      RESEARCH & DEVELOPMENT   107

5.5.2      MANUFACTURING & PRODUCTION       107

5.5.3      DISTRIBUTION 107

5.5.4      MARKETING & SALES    107

5.5.5      POST-SALES SERVICES 107

FIGURE 23         MENTAL HEALTH SCREENING MARKET: VALUE CHAIN ANALYSIS          108

5.6         ECOSYSTEM ANALYSIS 108

5.7         PORTER’S FIVE FORCES ANALYSIS         109

TABLE 4             PORTER’S FIVE FORCES ANALYSIS: MENTAL HEALTH SCREENING MARKET    109

5.7.1      INTENSITY OF COMPETITIVE RIVALRY 110

5.7.2      BARGAINING POWER OF SUPPLIERS     110

5.7.3      BARGAINING POWER OF BUYERS           110

5.7.4      THREAT OF NEW ENTRANTS    110

5.7.5      THREAT OF SUBSTITUTES         110

5.8         REGULATORY LANDSCAPE       111

5.8.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          111

TABLE 5             REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          111

5.8.2      REGULATORY ANALYSIS            112

5.8.2.1   North America     112

5.8.2.2   Europe  112

5.8.2.3   Asia Pacific          113

5.8.2.4   Latin America      113

5.8.2.5   Middle East & Africa          113

5.9         TECHNOLOGY ANALYSIS           114

5.9.1      KEY TECHNOLOGIES    114

5.9.1.1   Artificial Intelligence (AI) & Machine Learning (ML) 114

5.9.1.2   Telehealth platforms         114

5.9.1.3   Mobile apps and platforms 114

5.9.2      COMPLEMENTARY TECHNOLOGIES     114

5.9.2.1   Electronic Health Records (EHRs)  114

5.9.2.2   Chatbots and virtual assistants         114

5.9.3      ADJACENT TECHNOLOGIES      115

5.9.3.1   Genetic and biological markers        115

5.10       PATENT ANALYSIS        115

5.10.1    PATENT PUBLICATION TRENDS FOR MENTAL HEALTH SCREENING              115

5.10.2    JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES             115

FIGURE 24         JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR MENTAL HEALTH SCREENING PATENTS, 2012–2023       115

5.10.3    MAJOR PATENTS IN MENTAL HEALTH SCREENING MARKET     116

FIGURE 25         MAJOR PATENTS FOR MENTAL HEALTH SCREENING SOLUTIONS (2012–2023)             116

5.10.4    PATENTS FILED             117

5.11       TRADE ANALYSIS          119

FIGURE 26         PRODUCT EXPORTS UNDER HSN CODE: 9113, BY COUNTRY, 2022 (USD THOUSAND) 120

FIGURE 27         PRODUCT IMPORTS UNDER HSN CODE 9113, BY COUNTRY, 2022 (USD THOUSAND) 120

5.12       CASE STUDY ANALYSIS 121

TABLE 6             CASE STUDY 1: AIBERRY’S COLLABORATIVE CLINICAL STUDY WITH UNIVERSITY OF ARIZONA FOR AI-POWERED MENTAL HEALTH SCREENING PLATFORM             121

TABLE 7             CASE STUDY 2: IMPACT OF MINDWISE SCREENING PROGRAM AT HARVARD UNIVERSITY        121

5.13       KEY CONFERENCES & EVENTS, 2024–2025           122

5.13.1    LIST OF KEY CONFERENCES & EVENTS IN MENTAL HEALTH SCREENING MARKET, 2024–2025             122

5.14       KEY STAKEHOLDERS & BUYING CRITERIA          124

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         124

TABLE 8             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MENTAL HEALTH SCREENING SOLUTIONS       124

TABLE 9             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY       125

5.14.2    BUYING CRITERIA         125

FIGURE 28         KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125

TABLE 10           KEY BUYING CRITERIA FOR MENTAL HEALTH SCREENING SOLUTIONS, BY TECHNOLOGY 125

5.15       UNMET NEEDS 126

TABLE 11           UNMET NEEDS IN MENTAL HEALTH SCREENING MARKET              126

5.15.1    END-USER EXPECTATIONS       127

TABLE 12           END-USER EXPECTATIONS IN MENTAL HEALTH SCREENING MARKET            127

5.16       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 128

FIGURE 29         REVENUE SHIFTS AND NEW REVENUE POCKETS FOR MENTAL HEALTH SCREENING MARKET  128

5.17       REIMBURSEMENT SCENARIO ANALYSIS             128

TABLE 13           CPT CODES AND REIMBURSEMENT ANALYSIS IN MENTAL HEALTH SCREENING MARKET IN US      129

5.18       BUSINESS MODEL ANALYSIS     129

5.19       INVESTMENT & FUNDING SCENARIO    130

FIGURE 30         INVESTOR DEALS AND VC FUNDING OF US-BASED MENTAL HEALTH STARTUPS INCREASED IN 2020             130

6            MENTAL HEALTH SCREENING MARKET, BY APPLICATION        131

6.1         INTRODUCTION            132

TABLE 14           MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)          132

TABLE 15           MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          133

6.2         PHYSIOLOGICAL DISORDERS   133

TABLE 16           MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            133

TABLE 17           MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            134

TABLE 18           MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   134

TABLE 19           MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   135

6.2.1      DEPRESSION    135

6.2.1.1   Increased adoption of depression screening to drive market       135

TABLE 20           MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2018–2021 (USD MILLION)    137

TABLE 21           MENTAL HEALTH SCREENING MARKET FOR DEPRESSION, BY COUNTRY, 2022–2029 (USD MILLION)    138

6.2.2      ANXIETY            138

6.2.2.1   Increasing burden of anxiety disorders & rising awareness to fuel market growth              138

TABLE 22           MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2018–2021 (USD MILLION)    140

TABLE 23           MENTAL HEALTH SCREENING MARKET FOR ANXIETY, BY COUNTRY, 2022–2029 (USD MILLION)    141

6.2.3      POST-TRAUMATIC STRESS DISORDER (PTSD)  141

6.2.3.1   Rising number of initiatives for PTSD to propel market             141

TABLE 24           MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2018–2021 (USD MILLION)          142

TABLE 25           MENTAL HEALTH SCREENING MARKET FOR POST-TRAUMATIC STRESS DISORDER (PTSD), BY COUNTRY, 2022–2029 (USD MILLION)          143

6.2.4      BIPOLAR DISORDER      143

6.2.4.1   Growing public awareness to drive bipolar disorder screening uptake       143

TABLE 26           MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)     144

TABLE 27           MENTAL HEALTH SCREENING MARKET FOR BIPOLAR DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)     145

6.2.5      EATING DISORDER       145

6.2.5.1   Increasing incidence and hospital visits to drive adoption of eating disorder screening             145

FIGURE 31         GLOBAL EATING DISORDER PREVALENCE, BY AGE, 2015–2019              146

TABLE 28           MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)     147

TABLE 29           MENTAL HEALTH SCREENING MARKET FOR EATING DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)     147

6.2.6      SUBSTANCE USE            148

6.2.6.1   Increasing cases of substance use to drive market         148

TABLE 30           MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2018–2021 (USD MILLION)            149

TABLE 31           MENTAL HEALTH SCREENING MARKET FOR SUBSTANCE USE, BY COUNTRY, 2022–2029 (USD MILLION)            150

6.2.7      OTHER PHYSIOLOGICAL DISORDERS   150

TABLE 32           MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION) 151

TABLE 33           MENTAL HEALTH SCREENING MARKET FOR OTHER PHYSIOLOGICAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION) 151

6.3         PSYCHIATRIC DISORDERS         152

TABLE 34           MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            152

TABLE 35           MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            152

TABLE 36           MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   153

TABLE 37           MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   153

6.3.1      SCHIZOPHRENIA           154

6.3.1.1   Advancements in screening tools for schizophrenia to support growth     154

TABLE 38           MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2018–2021 (USD MILLION)            155

TABLE 39           MENTAL HEALTH SCREENING MARKET FOR SCHIZOPHRENIA, BY COUNTRY, 2022–2029 (USD MILLION)            155

6.3.2      PSYCHOTIC DISORDER 156

6.3.2.1   Increasing need for screening tools for early detection to drive market growth              156

TABLE 40           MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)     156

TABLE 41           MENTAL HEALTH SCREENING MARKET FOR PSYCHOTIC DISORDER,

BY COUNTRY, 2022–2029 (USD MILLION)            157

6.3.3      DISSOCIATIVE DISORDER          157

6.3.3.1   Growing awareness and education through screening and content creation to favor market growth     157

TABLE 42           MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2018–2021 (USD MILLION)     158

TABLE 43           MENTAL HEALTH SCREENING MARKET FOR DISSOCIATIVE DISORDER, BY COUNTRY, 2022–2029 (USD MILLION)     159

6.3.4      OBSESSIVE COMPULSIVE DISORDER (OCD)      159

6.3.4.1   Advancements in assessment tools to support market growth     159

TABLE 44           MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2018–2021 (USD MILLION)              160

TABLE 45           MENTAL HEALTH SCREENING MARKET FOR OBSESSIVE COMPULSIVE DISORDER (OCD), BY COUNTRY, 2022–2029 (USD MILLION)              160

6.3.5      ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)        161

6.3.5.1   Increasing cases & diagnosis to contribute to increased demand for ADHD screening             161

TABLE 46           MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2018–2021 (USD MILLION)          161

TABLE 47           MENTAL HEALTH SCREENING MARKET FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY COUNTRY, 2022–2029 (USD MILLION)          162

6.3.6      OTHER PSYCHIATRIC DISORDERS         162

TABLE 48           MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)      163

TABLE 49           MENTAL HEALTH SCREENING MARKET FOR OTHER PSYCHIATRIC DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)      163

6.4         BEHAVIORAL DISORDERS          164

TABLE 50           MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,

BY TYPE, 2018–2021 (USD MILLION)       164

TABLE 51           MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,

BY TYPE, 2022–2029 (USD MILLION)       164

TABLE 52           MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,

BY COUNTRY, 2018–2021 (USD MILLION)            165

TABLE 53           MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS,

BY COUNTRY, 2022–2029 (USD MILLION)            165

6.4.1      SELF-HARM      166

6.4.1.1   Advancements in screening technologies to drive awareness and growth in self-harm screening market      166

TABLE 54           MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   166

TABLE 55           MENTAL HEALTH SCREENING MARKET FOR SELF-HARM DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   167

6.4.2      AGGRESSION    167

6.4.2.1   Rising cases of workplace aggression to propel demand for aggression screening              167

TABLE 56           MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   168

TABLE 57           MENTAL HEALTH SCREENING MARKET FOR AGGRESSION DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   168

6.4.3      SLEEP DISORDERS        169

6.4.3.1   Increased stress and unhealthy lifestyles among adults to drive market     169

TABLE 58           MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   170

TABLE 59           MENTAL HEALTH SCREENING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   170

6.4.4      SOCIAL WITHDRAWAL 171

6.4.4.1   Increasing adolescent loneliness to drive demand for social withdrawal screening              171

TABLE 60           MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)    172

TABLE 61           MENTAL HEALTH SCREENING MARKET FOR SOCIAL WITHDRAWAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)    172

6.4.5      HYPERACTIVITY            173

6.4.5.1   Increased awareness and recognition to drive growth   173

TABLE 62           MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   173

TABLE 63           MENTAL HEALTH SCREENING MARKET FOR HYPERACTIVITY DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   174

6.4.6      OTHER BEHAVIORAL DISORDERS          174

TABLE 64           MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)      175

TABLE 65           MENTAL HEALTH SCREENING MARKET FOR OTHER BEHAVIORAL DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)      175

6.5         COGNITIVE DISORDERS             176

TABLE 66           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            176

TABLE 67           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            176

TABLE 68           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)   177

TABLE 69           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)   178

6.5.1      COGNITIVE IMPAIRMENT          178

6.5.1.1   Growing geriatric population and rising incidence of neurodegenerative disorders to support market growth   178

TABLE 70           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2018–2021 (USD MILLION) 179

TABLE 71           MENTAL HEALTH SCREENING MARKET FOR COGNITIVE IMPAIRMENT, BY COUNTRY, 2022–2029 (USD MILLION) 180

6.5.2      DEMENTIA        180

6.5.2.1   Rising initiatives to promote dementia screening awareness to fuel market              180

TABLE 72           MENTAL HEALTH SCREENING MARKET FOR DEMENTIA, BY COUNTRY, 2018–2021 (USD MILLION)    181

TABLE 73           MENTAL HEALTH SCREENING MARKET FOR DEMENTIA FOR, BY COUNTRY, 2022–2029 (USD MILLION)            182

6.5.3      ALZHEIMER’S DISEASE 182

6.5.3.1   Favorable initiatives and increased access to screening to drive market    182

TABLE 74           MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2018–2021 (USD MILLION)         183

TABLE 75           MENTAL HEALTH SCREENING MARKET FOR ALZHEIMER’S DISEASE, BY COUNTRY, 2022–2029 (USD MILLION)         184

6.5.4      OTHER COGNITIVE DISORDERS             184

TABLE 76           MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2018–2021 (USD MILLION)         185

TABLE 77           MENTAL HEALTH SCREENING MARKET FOR OTHER COGNITIVE DISORDERS, BY COUNTRY, 2022–2029 (USD MILLION)         185

7            MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD              186

7.1         INTRODUCTION            187

TABLE 78           MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)     187

TABLE 79           MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)     187

7.2         SELF-REPORTED QUESTIONNAIRES & SURVEYS             188

TABLE 80           MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)        188

TABLE 81           MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)        189

TABLE 82           MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION)              189

TABLE 83           MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION)              190

7.2.1      BECK DEPRESSION INVENTORY (BDI)   190

7.2.1.1   Increasing prevalence of depression to drive demand for BDI    190

TABLE 84           MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2018–2021 (USD MILLION)              191

TABLE 85           MENTAL HEALTH SCREENING MARKET FOR BECK DEPRESSION INVENTORY (BDI), BY COUNTRY, 2022–2029 (USD MILLION)              192

7.2.2      GENERALIZED ANXIETY DISORDER-7 (GAD-7)  192

7.2.2.1   Growing concerns regarding anxiety disorders in adults to boost market  192

TABLE 86           MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2018–2021 (USD MILLION)              193

TABLE 87           MENTAL HEALTH SCREENING MARKET FOR GENERALIZED ANXIETY DISORDER-7 (GAD-7), BY COUNTRY, 2022–2029 (USD MILLION)              194

7.2.3      HAMILTON ANXIETY RATING SCALE (HAM-A)  194

7.2.3.1   Increasing demand for standardized & reliable assessment tools to favor market growth   194

TABLE 88           MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2018–2021 (USD MILLION)              195

TABLE 89           MENTAL HEALTH SCREENING MARKET FOR HAMILTON ANXIETY RATING SCALE (HAM-A), BY COUNTRY, 2022–2029 (USD MILLION)              196

7.2.4      PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12)           196

7.2.4.1   Growing focus on early intervention to boost demand  196

TABLE 90           MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2018–2021 (USD MILLION)          197

TABLE 91           MENTAL HEALTH SCREENING MARKET FOR PATIENT HEALTH QUESTIONNAIRE-12 (PHQ-12), BY COUNTRY, 2022–2029 (USD MILLION)          198

7.2.5      YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS)           198

7.2.5.1   Rising awareness of obsessive compulsive disorder (OCD) to fuel growth 198

TABLE 92           MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2018–2021 (USD MILLION)          199

TABLE 93           MENTAL HEALTH SCREENING MARKET FOR YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS), BY COUNTRY, 2022–2029 (USD MILLION)          200

7.2.6      OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS             200

TABLE 94           MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2018–2021 (USD MILLION)          201

TABLE 95           MENTAL HEALTH SCREENING MARKET FOR OTHER SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY COUNTRY, 2022–2029 (USD MILLION)          202

7.3         CLINICAL INTERVIEWS 202

TABLE 96           MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          203

TABLE 97           MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          203

TABLE 98           MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 204

TABLE 99           MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 205

7.3.1      MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI)              205

7.3.1.1   Increasing global burden of psychiatric disorders to boost market growth 205

TABLE 100         MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2018–2021 (USD MILLION)          206

TABLE 101         MENTAL HEALTH SCREENING MARKET FOR MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW (MINI), BY COUNTRY, 2022–2029 (USD MILLION)          207

7.3.2      STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID) 207

7.3.2.1   Growing demand for comprehensive & detail assessment screening methods to favor market growth           207

TABLE 102         MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2018–2021 (USD MILLION)          208

TABLE 103         MENTAL HEALTH SCREENING MARKET FOR STRUCTURED CLINICAL INTERVIEWS FOR DSM (SCID), BY COUNTRY, 2022–2029 (USD MILLION)          209

7.3.3      DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD)              209

7.3.3.1   Increasing prevalence of psychological distress post pandemic to drive demand for DIPD    209

TABLE 104         MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2018–2021 (USD MILLION) 210

TABLE 105         MENTAL HEALTH SCREENING MARKET FOR DIAGNOSTIC INTERVIEW FOR PSYCHOLOGICAL DISTRESS (DIPD), BY COUNTRY, 2022–2029 (USD MILLION) 211

7.3.4      OTHER CLINICAL INTERVIEWS 211

TABLE 106         MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2018–2021 (USD MILLION) 212

TABLE 107         MENTAL HEALTH SCREENING MARKET FOR OTHER CLINICAL INTERVIEWS, BY COUNTRY, 2022–2029 (USD MILLION) 213

7.4         OBSERVATION-BASED ASSESSMENTS   213

7.4.1      ADVANCES IN WEARABLE TECHNOLOGIES TO REVOLUTIONIZE OBSERVATION-BASED ASSESSMENT TOOLS     213

TABLE 108         MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2018–2021 (USD MILLION) 214

TABLE 109         MENTAL HEALTH SCREENING MARKET FOR OBSERVATION-BASED ASSESSMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 215

7.5         BIOMARKER TESTING  215

7.5.1      ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING TO DRIVE ADOPTION OF BIOMARKER TESTING TECHNOLOGIES          215

TABLE 110         MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018–2021 (USD MILLION)        216

TABLE 111         MENTAL HEALTH SCREENING MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2022–2029 (USD MILLION)        217

8            MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY       218

8.1         INTRODUCTION            219

TABLE 112         MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          219

TABLE 113         MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          219

8.2         SELF-SCREENING MHEALTH APPS         220

8.2.1      INCREASING AWARENESS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF MHEALTH APPS IN FUTURE  220

TABLE 114         MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2018–2021 (USD MILLION)         221

TABLE 115         MENTAL HEALTH SCREENING MARKET FOR SELF-SCREENING MHEALTH APPS, BY COUNTRY, 2022–2029 (USD MILLION)         222

8.3         TELEHEALTH & VIRTUAL CARE SOLUTIONS     222

8.3.1      RISING DEMAND FOR ACCESSIBLE AND CONVENIENT HEALTHCARE SERVICES TO FUEL MARKET GROWTH 222

TABLE 116         MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2018–2021 (USD MILLION)   223

TABLE 117         MENTAL HEALTH SCREENING MARKET FOR TELEHEALTH & VIRTUAL CARE SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)   224

8.4         CONTINUOUS MONITORING WEARABLE DEVICES        224

8.4.1      SHIFT TOWARDS PROACTIVE AND PERSONALIZED HEALTHCARE TO DRIVE MARKET GROWTH          224

TABLE 118         MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2018–2021 (USD MILLION)              225

TABLE 119         MENTAL HEALTH SCREENING MARKET FOR CONTINUOUS MONITORING WEARABLE DEVICES, BY COUNTRY, 2022–2029 (USD MILLION)              226

8.5         AI-BASED SCREENING TOOLS   226

8.5.1      HIGH COST ASSOCIATED WITH AI-BASED SCREENING TOOLS TO RESTRAIN MARKET GROWTH   226

TABLE 120         MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2018–2021 (USD MILLION)   227

TABLE 121         MENTAL HEALTH SCREENING MARKET FOR AI-BASED SCREENING TOOLS, BY COUNTRY, 2022–2029 (USD MILLION)   228

8.6         REMOTE MENTAL HEALTH PLATFORMS            228

8.6.1      INCREASED ADOPTION OF REMOTE MENTAL HEALTH SCREENING PLATFORMS TO FAVOR MARKET GROWTH       228

TABLE 122         MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION)              229

TABLE 123         MENTAL HEALTH SCREENING MARKET FOR REMOTE MENTAL HEALTH PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION)              230

9            MENTAL HEALTH SCREENING MARKET, BY AGE GROUP            231

9.1         INTRODUCTION            232

TABLE 124         MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)     232

TABLE 125         MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)     232

9.2         CHILDREN & ADOLESCENTS (AGE 0–18 YEARS) 233

9.2.1      GROWING PREVALENCE OF MENTAL HEALTH DISORDERS IN CHILDREN & ADOLESCENTS TO DRIVE MARKET GROWTH        233

TABLE 126         MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2018–2021 (USD MILLION) 234

TABLE 127         MENTAL HEALTH SCREENING MARKET FOR CHILDREN & ADOLESCENTS (0–18 YEARS), BY COUNTRY, 2022–2029 (USD MILLION) 235

9.3         ADULTS (AGE 19–64 YEARS)      235

9.3.1      GROWING POPULARITY OF WORKPLACE WELLNESS PROGRAMS TO BOOST DEMAND FOR MENTAL HEALTH SCREENING    235

TABLE 128         MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2018–2021 (USD MILLION)      236

TABLE 129         MENTAL HEALTH SCREENING MARKET FOR ADULTS (AGE 19–64 YEARS), BY COUNTRY, 2022–2029 (USD MILLION)      237

9.4         SENIORS (AGE 65 AND ABOVE) 237

9.4.1      GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN AGE-RELATED MENTAL DISORDERS TO BOOST MARKET          237

TABLE 130         MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2018–2021 (USD MILLION) 238

TABLE 131         MENTAL HEALTH SCREENING MARKET FOR SENIORS (AGE 65 AND ABOVE), BY COUNTRY, 2022–2029 (USD MILLION) 239

10          MENTAL HEALTH SCREENING MARKET, BY SETTING   240

10.1       INTRODUCTION            241

TABLE 132         MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)     241

TABLE 133         MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)     241

10.2       CLINICAL SETTINGS     242

10.2.1    SHIFT TOWARDS PREVENTIVE AND PATIENT-CENTRED CARE TO DRIVE MARKET GROWTH          242

TABLE 134         MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)      242

TABLE 135         MENTAL HEALTH SCREENING MARKET FOR CLINICAL SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)      243

10.3       EDUCATIONAL INSTITUTIONS 243

10.3.1    GROWING INITIATIVES TO BOOST GROWTH    243

TABLE 136         MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2018–2021 (USD MILLION)           244

TABLE 137         MENTAL HEALTH SCREENING MARKET FOR EDUCATIONAL INSTITUTIONS, BY COUNTRY, 2022–2029 (USD MILLION)           245

10.4       WORKPLACE/CORPORATE PROGRAMS 245

10.4.1    RISING MENTAL HEALTH CHALLENGES AND DUTY OF CARE TO DRIVE MARKET GROWTH        245

TABLE 138         MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2018–2021 (USD MILLION)          246

TABLE 139         MENTAL HEALTH SCREENING MARKET FOR WORKPLACE/CORPORATE PROGRAMS, BY COUNTRY, 2022–2029 (USD MILLION)          247

10.5       ONLINE PLATFORMS    247

10.5.1    ACCESSIBLE AND PERSONALIZED ASSESSMENTS TO DRIVE DEMAND              247

TABLE 140         MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2018–2021 (USD MILLION)  248

TABLE 141         MENTAL HEALTH SCREENING MARKET FOR ONLINE PLATFORMS, BY COUNTRY, 2022–2029 (USD MILLION)  249

10.6       OTHER SETTINGS         249

TABLE 142        MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2018–2021 (USD MILLION)            250

TABLE 143        MENTAL HEALTH SCREENING MARKET FOR OTHER SETTINGS, BY COUNTRY, 2022–2029 (USD MILLION)            251

11          MENTAL HEALTH SCREENING MARKET, BY REGION     252

11.1       INTRODUCTION            253

TABLE 144         MENTAL HEALTH SCREENING MARKET, BY REGION, 2018–2021 (USD MILLION) 253

TABLE 145         MENTAL HEALTH SCREENING MARKET, BY REGION, 2022–2029 (USD MILLION) 253

11.2       NORTH AMERICA          254

FIGURE 32         NORTH AMERICA: MARKET SNAPSHOT 255

TABLE 146         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)    255

TABLE 147         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    256

TABLE 148         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           256

TABLE 149         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           256

TABLE 150         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         257

TABLE 151         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         257

TABLE 152         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 258

TABLE 153         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 258

TABLE 154         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 259

TABLE 155         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 259

TABLE 156         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    260

TABLE 157         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    260

TABLE 158         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           260

TABLE 159         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           261

TABLE 160         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          261

TABLE 161         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          262

TABLE 162         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      262

TABLE 163         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      263

TABLE 164         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          263

TABLE 165         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          264

TABLE 166         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 264

TABLE 167         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 265

TABLE 168         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      265

TABLE 169         NORTH AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      266

11.2.1    NORTH AMERICA: RECESSION IMPACT 266

11.2.2    US         266

11.2.2.1 US to dominate North American mental health screening market            266

TABLE 170         US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)          267

TABLE 171         US: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          267

TABLE 172         US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         268

TABLE 173         US: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         268

TABLE 174         US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            269

TABLE 175         US: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            269

TABLE 176         US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            270

TABLE 177         US: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            270

TABLE 178         US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            271

TABLE 179         US: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            271

TABLE 180         US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)     271

TABLE 181         US: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)     272

TABLE 182         US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              272

TABLE 183         US: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              273

TABLE 184         US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          273

TABLE 185         US: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          274

TABLE 186         US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          274

TABLE 187         US: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          275

TABLE 188         US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)          275

TABLE 189         US: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)          275

TABLE 190         US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)     276

TABLE 191         US: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)     276

11.2.3    CANADA            276

11.2.3.1 Growing investments in mental health and well-being to contribute to market growth   276

TABLE 192         CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           277

TABLE 193         CANADA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           277

TABLE 194         CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         278

TABLE 195         CANADA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         278

TABLE 196         CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 279

TABLE 197         CANADA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 279

TABLE 198         CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 280

TABLE 199         CANADA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 280

TABLE 200         CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    281

TABLE 201         CANADA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    281

TABLE 202         CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           281

TABLE 203         CANADA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           282

TABLE 204         CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              282

TABLE 205         CANADA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              283

TABLE 206         CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      283

TABLE 207         CANADA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      284

TABLE 208         CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          284

TABLE 209         CANADA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          285

TABLE 210         CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         285

TABLE 211         CANADA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         286

TABLE 212        CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          286

TABLE 213        CANADA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          286

11.3       EUROPE             287

TABLE 214         EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)    287

TABLE 215         EUROPE: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    288

TABLE 216         EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           288

TABLE 217         EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           288

TABLE 218         EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         289

TABLE 219         EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         289

TABLE 220         EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 290

TABLE 221         EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 290

TABLE 222         EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 291

TABLE 223         EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 291

TABLE 224         EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    292

TABLE 225         EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    292

TABLE 226         EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           292

TABLE 227         EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           293

TABLE 228         EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              293

TABLE 229         EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              294

TABLE 230         EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      294

TABLE 231         EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      295

TABLE 232         EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          295

TABLE 233         EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          296

TABLE 234         EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         296

TABLE 235         EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         297

TABLE 236         EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          297

TABLE 237         EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          297

11.3.1    EUROPE: RECESSION IMPACT   298

11.3.2    UK         298

11.3.2.1 Long waiting periods and inadequate access to care to favor market growth              298

TABLE 238         UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)          299

TABLE 239         UK: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          299

TABLE 240         UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         300

TABLE 241         UK: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         300

TABLE 242         UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            301

TABLE 243         UK: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            301

TABLE 244         UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            302

TABLE 245         UK: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            302

TABLE 246         UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)            303

TABLE 247         UK: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)            303

TABLE 248         UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)     303

TABLE 249         UK: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)     304

TABLE 250         UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              304

TABLE 251         UK: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              305

TABLE 252         UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          305

TABLE 253         UK: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          306

TABLE 254        UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          306

TABLE 255        UK: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          307

TABLE 256         UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)          307

TABLE 257         UK: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)          307

TABLE 258         UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          308

TABLE 259         UK: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          308

11.3.3    GERMANY         308

11.3.3.1 Large patient base and growing burden on health providers to drive demand for HCIT solutions    308

TABLE 260         GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           309

TABLE 261         GERMANY: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           309

TABLE 262         GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         310

TABLE 263         GERMANY: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         310

TABLE 264         GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 311

TABLE 265         GERMANY: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 311

TABLE 266         GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 312

TABLE 267         GERMANY: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 312

TABLE 268         GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    313

TABLE 269         GERMANY: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    313

TABLE 270         GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           313

TABLE 271         GERMANY: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           314

TABLE 272         GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              314

TABLE 273         GERMANY: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              315

TABLE 274         GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      315

TABLE 275         GERMANY: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      316

TABLE 276         GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          316

TABLE 277         GERMANY: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          317

TABLE 278         GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         317

TABLE 279         GERMANY: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         318

TABLE 280         GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      318

TABLE 281         GERMANY: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      319

11.3.4    FRANCE             319

11.3.4.1 High prevalence of behavioral disorders to drive support for implementing mental health screening solutions in France 319

TABLE 282         FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           319

TABLE 283         FRANCE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           320

TABLE 284         FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         320

TABLE 285         FRANCE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         321

TABLE 286         FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 321

TABLE 287         FRANCE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 322

TABLE 288         FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 322

TABLE 289         FRANCE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 323

TABLE 290         FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    323

TABLE 291         FRANCE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    324

TABLE 292         FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           324

TABLE 293         FRANCE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           325

TABLE 294         FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              325

TABLE 295         FRANCE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              326

TABLE 296         FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      326

TABLE 297         FRANCE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      327

TABLE 298         FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          327

TABLE 299         FRANCE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          328

TABLE 300         FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         328

TABLE 301         FRANCE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         329

TABLE 302         FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          329

TABLE 303         FRANCE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          329

11.3.5    REST OF EUROPE           330

TABLE 304         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           330

TABLE 305         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           331

TABLE 306         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         331

TABLE 307         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         332

TABLE 308         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 332

TABLE 309         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 333

TABLE 310         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 333

TABLE 311         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 334

TABLE 312         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    334

TABLE 313         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    335

TABLE 314         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           335

TABLE 315         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           336

TABLE 316         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          336

TABLE 317         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          337

TABLE 318         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      337

TABLE 319         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      338

TABLE 320         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          338

TABLE 321         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          339

TABLE 322         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 339

TABLE 323         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 340

TABLE 324         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      340

TABLE 325         REST OF EUROPE: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      341

11.4       ASIA PACIFIC    341

FIGURE 33         ASIA PACIFIC: MARKET SNAPSHOT       342

TABLE 326         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)    343

TABLE 327         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    343

TABLE 328         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           343

TABLE 329         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           344

TABLE 330         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         344

TABLE 331         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         345

TABLE 332         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 345

TABLE 333         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 346

TABLE 334         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 346

TABLE 335         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 347

TABLE 336         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    347

TABLE 337         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    348

TABLE 338         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           348

TABLE 339         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           349

TABLE 340         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          349

TABLE 341         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          350

TABLE 342         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      350

TABLE 343         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      351

TABLE 344         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          351

TABLE 345         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          352

TABLE 346         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         352

TABLE 347         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         353

TABLE 348         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      353

TABLE 349         ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      354

11.4.1    ASIA PACIFIC: RECESSION IMPACT        354

11.4.2    CHINA  354

11.4.2.1 Rising incidence of mental illnesses to drive demand for care solutions in China              354

TABLE 350         CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           355

TABLE 351         CHINA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           355

TABLE 352         CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         356

TABLE 353         CHINA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         356

TABLE 354         CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 357

TABLE 355         CHINA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 357

TABLE 356         CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 358

TABLE 357         CHINA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 358

TABLE 358         CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    359

TABLE 359         CHINA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    359

TABLE 360         CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           359

TABLE 361         CHINA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           360

TABLE 362         CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              360

TABLE 363         CHINA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              361

TABLE 364         CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          361

TABLE 365         CHINA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          362

TABLE 366         CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          362

TABLE 367         CHINA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          363

TABLE 368         CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         363

TABLE 369         CHINA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         364

TABLE 370         CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          364

TABLE 371         CHINA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          364

11.4.3    JAPAN  365

11.4.3.1 Rising geriatric population in Japan and subsequent increase in age-related mental disorders to boost market   365

TABLE 372         JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           365

TABLE 373         JAPAN: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           366

TABLE 374         JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         366

TABLE 375         JAPAN: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         367

TABLE 376         JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 367

TABLE 377         JAPAN: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 368

TABLE 378         JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 368

TABLE 379         JAPAN: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 369

TABLE 380         JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    369

TABLE 381         JAPAN: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    370

TABLE 382         JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           370

TABLE 383         JAPAN: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           371

TABLE 384         JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              371

TABLE 385         JAPAN: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              372

TABLE 386         JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          372

TABLE 387         JAPAN: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          373

TABLE 388         JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          373

TABLE 389         JAPAN: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          374

TABLE 390         JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         374

TABLE 391         JAPAN: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         375

TABLE 392         JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          375

TABLE 393         JAPAN: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          375

11.4.4    INDIA   376

11.4.4.1 Inadequate workforce and lack of access to drive adoption of solutions     376

TABLE 394         INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           376

TABLE 395         INDIA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           377

TABLE 396         INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         377

TABLE 397         INDIA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         378

TABLE 398         INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 378

TABLE 399         INDIA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 379

TABLE 400         INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 379

TABLE 401         INDIA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 380

TABLE 402         INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    380

TABLE 403         INDIA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    381

TABLE 404         INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)     381

TABLE 405         INDIA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)     382

TABLE 406         INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              382

TABLE 407         INDIA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              383

TABLE 408         INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          383

TABLE 409         INDIA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          384

TABLE 410         INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          384

TABLE 411         INDIA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          385

TABLE 412         INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         385

TABLE 413         INDIA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         386

TABLE 414         INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          386

TABLE 415         INDIA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          386

11.4.5    REST OF ASIA PACIFIC  387

TABLE 416        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)     387

TABLE 417        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     388

TABLE 418         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 388

TABLE 419         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 389

TABLE 420         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)      389

TABLE 421         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)      390

TABLE 422         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)       390

TABLE 423         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)       391

TABLE 424         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          391

TABLE 425         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          392

TABLE 426        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)     392

TABLE 427        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)     393

TABLE 428         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          393

TABLE 429         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          394

TABLE 430         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)            394

TABLE 431         REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)            395

TABLE 432        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)    395

TABLE 433        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    396

TABLE 434        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         396

TABLE 435        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         397

TABLE 436        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION) 397

TABLE 437        REST OF ASIA PACIFIC: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION) 398

11.5       LATIN AMERICA             398

TABLE 438         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)    399

TABLE 439         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)    399

TABLE 440         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           399

TABLE 441         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           400

TABLE 442         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         400

TABLE 443         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         401

TABLE 444         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 401

TABLE 445         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 402

TABLE 446         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 402

TABLE 447         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 403

TABLE 448         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    403

TABLE 449         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    404

TABLE 450         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           404

TABLE 451         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           405

TABLE 452         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          405

TABLE 453         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          406

TABLE 454         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      406

TABLE 455         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      407

TABLE 456         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          407

TABLE 457         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          408

TABLE 458         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 408

TABLE 459         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 409

TABLE 460         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      409

TABLE 461         LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      410

11.5.1    LATIN AMERICA: RECESSION IMPACT   410

11.5.2    BRAZIL 410

11.5.2.1 Large healthcare industry and increased investments in healthcare to boost market              410

TABLE 462         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           411

TABLE 463         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           411

TABLE 464         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         412

TABLE 465         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         412

TABLE 466         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 413

TABLE 467         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 413

TABLE 468         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 414

TABLE 469         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 414

TABLE 470         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    415

TABLE 471         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    415

TABLE 472         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           415

TABLE 473         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           416

TABLE 474         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              416

TABLE 475         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              417

TABLE 476         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      417

TABLE 477         BRAZIL: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      418

TABLE 478         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          418

TABLE 479         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          419

TABLE 480         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         419

TABLE 481         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         420

TABLE 482         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          420

TABLE 483         BRAZIL: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          420

11.5.3    MEXICO             421

11.5.3.1 Growing number of mental health patients to drive market        421

TABLE 484         MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           421

TABLE 485         MEXICO: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           422

TABLE 486         MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         422

TABLE 487         MEXICO: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         423

TABLE 488         MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 423

TABLE 489         MEXICO: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 424

TABLE 490         MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 424

TABLE 491         MEXICO: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 425

TABLE 492         MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    425

TABLE 493         MEXICO: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    425

TABLE 494         MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           426

TABLE 495         MEXICO: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           426

TABLE 496         MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)              427

TABLE 497         MEXICO: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)              427

TABLE 498         MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      428

TABLE 499         MEXICO: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      428

TABLE 500         MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          429

TABLE 501         MEXICO: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          429

TABLE 502         MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)         429

TABLE 503         MEXICO: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)         430

TABLE 504         MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)          430

TABLE 505         MEXICO: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)          430

11.5.4    REST OF LATIN AMERICA          431

TABLE 506         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)  431

TABLE 507         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  431

TABLE 508         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          432

TABLE 509         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          432

TABLE 510         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              433

TABLE 511         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              433

TABLE 512         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              434

TABLE 513         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              434

TABLE 514         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              435

TABLE 515         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              435

TABLE 516         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)  435

TABLE 517         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)  436

TABLE 518         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)     436

TABLE 519         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)     437

TABLE 520         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)              437

TABLE 521         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)              438

TABLE 522         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 438

TABLE 523         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 439

TABLE 524         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)     439

TABLE 525         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)     440

TABLE 526         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)           440

TABLE 527         REST OF LATIN AMERICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)           441

11.6       MIDDLE EAST & AFRICA             441

TABLE 528         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2018–2021 (USD MILLION)         442

TABLE 529         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         442

TABLE 530         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)  442

TABLE 531         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  443

TABLE 532         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          443

TABLE 533         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          444

TABLE 534         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              444

TABLE 535         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              445

TABLE 536         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              445

TABLE 537         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              446

TABLE 538         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)              446

TABLE 539         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)              447

TABLE 540         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)  447

TABLE 541         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)  448

TABLE 542         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)     448

TABLE 543         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)     449

TABLE 544         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)              449

TABLE 545         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)              450

TABLE 546         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION) 450

TABLE 547         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 451

TABLE 548         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)     451

TABLE 549         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)     452

TABLE 550         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)           452

TABLE 551         MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)           452

11.6.1    MIDDLE EAST & AFRICA: RECESSION IMPACT   453

11.6.2    GCC COUNTRIES           453

11.6.2.1 Growing initiatives to address mental health issues to drive growth          453

TABLE 552         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)           453

TABLE 553         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)           454

TABLE 554         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)         454

TABLE 555         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)         455

TABLE 556         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 455

TABLE 557         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 456

TABLE 558         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 456

TABLE 559         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 457

TABLE 560         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)    457

TABLE 561         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)    458

TABLE 562         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)           458

TABLE 563         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)           458

TABLE 564         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)          459

TABLE 565         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)          459

TABLE 566         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)      460

TABLE 567         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)      460

TABLE 568         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)          461

TABLE 569         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          461

TABLE 570         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION) 462

TABLE 571         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION) 462

TABLE 572         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)      462

TABLE 573         GCC COUNTRIES: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)      463

11.6.3    REST OF MIDDLE EAST & AFRICA           463

TABLE 574         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2018–2021 (USD MILLION)        463

TABLE 575         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)        464

TABLE 576         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION) 464

TABLE 577         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PHYSIOLOGICAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION) 465

TABLE 578         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          465

TABLE 579         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR PSYCHIATRIC DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          466

TABLE 580         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          466

TABLE 581         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR BEHAVIORAL DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          467

TABLE 582         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2018–2021 (USD MILLION)          467

TABLE 583         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR COGNITIVE DISORDERS, BY TYPE, 2022–2029 (USD MILLION)          468

TABLE 584         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2018–2021 (USD MILLION)              468

TABLE 585         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SCREENING METHOD, 2022–2029 (USD MILLION)              468

TABLE 586         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2018–2021 (USD MILLION)             469

TABLE 587         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR SELF-REPORTED QUESTIONNAIRES & SURVEYS, BY TYPE, 2022–2029 (USD MILLION)             469

TABLE 588         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2018–2021 (USD MILLION)          470

TABLE 589         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET FOR CLINICAL INTERVIEWS, BY TYPE, 2022–2029 (USD MILLION)          470

TABLE 590         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2018–2021 (USD MILLION)       471

TABLE 591         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)       471

TABLE 592         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2018–2021 (USD MILLION)           472

TABLE 593         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY AGE GROUP, 2022–2029 (USD MILLION)           472

TABLE 594         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2018–2021 (USD MILLION)   472

TABLE 595         REST OF MIDDLE EAST & AFRICA: MENTAL HEALTH SCREENING MARKET, BY SETTING, 2022–2029 (USD MILLION)   473

12          COMPETITIVE LANDSCAPE       474

12.1       OVERVIEW        474

12.2       STRATEGIES ADOPTED BY KEY PLAYERS           474

FIGURE 34         MENTAL HEALTH SCREENING MARKET: STRATEGIES ADOPTED BY KEY PLAYERS       475

12.3       REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS (2022)   476

FIGURE 35         MENTAL HEALTH SCREENING MARKET: REVENUE ANALYSIS FOR KEY PLAYERS, 2018–2022    476

12.4       MARKET SHARE ANALYSIS (2022)           476

12.4.1    MARKET SHARE ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET (2022)           476

FIGURE 36         MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: MARKET SHARE ANALYSIS FOR KEY PLAYERS, 2022        477

TABLE 596         MENTAL HEALTH SCREENING WEARABLE DEVICES MARKET: DEGREE OF COMPETITION       477

12.4.2    MARKET RANKING ANALYSIS OF KEY PLAYERS IN MENTAL HEALTH SCREENING MARKET (2022)      478

12.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   479

12.5.1    STARS  479

12.5.2    PERVASIVE PLAYERS     479

12.5.3    EMERGING LEADERS    479

12.5.4    PARTICIPANTS 479

FIGURE 37         MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      480

12.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      481

FIGURE 38         MENTAL HEALTH SCREENING MARKET: COMPANY FOOTPRINT      481

TABLE 597         MENTAL HEALTH SCREENING MARKET: REGION FOOTPRINT              482

TABLE 598         MENTAL HEALTH SCREENING MARKET: APPLICATION FOOTPRINT      483

TABLE 599         MENTAL HEALTH SCREENING MARKET: SCREENING METHOD FOOTPRINT      484

TABLE 600         MENTAL HEALTH SCREENING MARKET: TECHNOLOGY FOOTPRINT      485

TABLE 601         MENTAL HEALTH SCREENING MARKET: AGE GROUP FOOTPRINT      486

12.6       COMPANY EVALUATION MATRIX: SMES/STARTUPS, 2023          487

12.6.1    PROGRESSIVE COMPANIES       487

12.6.2    DYNAMIC COMPANIES 487

12.6.3    RESPONSIVE COMPANIES          487

12.6.4    STARTING BLOCKS       487

FIGURE 39         MENTAL HEALTH SCREENING MARKET: COMPANY EVALUATION MATRIX (SMES/START-UPS), 2023             488

12.6.5    COMPETITIVE BENCHMARKING: SMES/STARTUPS, 2023             489

TABLE 602         MENTAL HEALTH SCREENING MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS    489

TABLE 603         MENTAL HEALTH SCREENING MARKET: COMPETITIVE BENCHMARKING OF STARTUP/ SME PLAYERS  490

12.7       VALUATION AND FINANCIAL METRICS OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS        491

FIGURE 40         MENTAL HEALTH SCREENING MARKET: EV/EBITDA OF KEY VENDORS          491

FIGURE 41         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF MENTAL HEALTH SCREENING WEARABLE DEVICE VENDORS              491

12.8       PRODUCT COMPARATIVE ANALYSIS    492

FIGURE 42         MENTAL HEALTH SCREENING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS, BY SCREENING METHOD     492

12.8.1    TOTAL BRAIN PLATFORM         493

12.8.2    AIBERRY MENTAL HEALTH ASSESSMENT & SCREENING             493

12.8.3    HEADSPACE FOR WORK             493

12.8.4    QUARTET          493

12.9       COMPETITIVE SCENARIO          494

12.9.1    MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES 494

TABLE 604         MENTAL HEALTH SCREENING MARKET: PRODUCT LAUNCHES              494

12.9.2    MENTAL HEALTH SCREENING MARKET: DEALS             495

TABLE 605         MENTAL HEALTH SCREENING MARKET: DEALS             495

12.9.3    MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS              496

TABLE 606         MENTAL HEALTH SCREENING MARKET: OTHER DEVELOPMENTS           496

13          COMPANY PROFILES    497

13.1       KEY PLAYERS   497

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

13.1.1    SONDERMIND (TOTAL BRAIN) 497

TABLE 607         SONDERMIND: COMPANY OVERVIEW   497

TABLE 608         SONDERMIND: DEALS  498

TABLE 609         SONDERMIND: EXPANSIONS     499

13.1.2    RIVERSIDE COMMUNITY CARE (MINDWISE INNOVATIONS)      500

TABLE 610         RIVERSIDE COMMUNITY CARE: COMPANY OVERVIEW  500

13.1.3    PROEM BEHAVIORAL HEALTH 502

TABLE 611         PROEM BEHAVIORAL HEALTH: COMPANY OVERVIEW  502

TABLE 612         PROEM BEHAVIORAL HEALTH: DEALS 503

TABLE 613         PROEM BEHAVIORAL HEALTH: OTHER DEVELOPMENTS              504

13.1.4    HEADSPACE HEALTH   505

TABLE 614         HEADSPACE HEALTH: COMPANY OVERVIEW    505

13.1.5    QUARTET HEALTH, INC.            507

TABLE 615         QUARTET HEALTH, INC.: COMPANY OVERVIEW             507

TABLE 616         QUARTET HEALTH, INC.: DEALS            508

13.1.6    CLARIGENT HEALTH    510

TABLE 617         CLARIGENT HEALTH: COMPANY OVERVIEW     510

TABLE 618         CLARIGENT HEALTH: PRODUCT LAUNCHES     511

TABLE 619         CLARIGENT HEALTH: DEALS    511

13.1.7    ELLIPSIS HEALTH, INC. 512

TABLE 620         ELLIPSIS HEALTH: COMPANY OVERVIEW           512

TABLE 621         ELLIPSIS HEALTH, INC.: DEALS 513

13.1.8    ADAPTIVE TESTING TECHNOLOGIES   514

TABLE 622         ADAPTIVE TESTING TECHNOLOGIES: COMPANY OVERVIEW              514

13.1.9    AIBERRY            515

TABLE 623         AIBERRY: COMPANY OVERVIEW             515

TABLE 624         AIBERRY: PRODUCT ENHANCEMENTS  516

13.1.10  KINTSUGI MINDFUL WELLNESS, INC.    517

TABLE 625         KINTSUGI MINDFUL WELLNESS, INC.: COMPANY OVERVIEW              517

13.1.11  THYMIA LIMITED          518

TABLE 626         THYMIA LIMITED: COMPANY OVERVIEW           518

13.1.12  CANARY SPEECH, INC.  519

TABLE 627         CANARY SPEECH, INC.: COMPANY OVERVIEW   519

TABLE 628         CANARY SPEECH, INC.: DEALS  520

13.1.13  MODERN LIFE, INC.       521

TABLE 629         MODERN LIFE, INC.: COMPANY OVERVIEW       521

13.1.14  SONDE HEALTH, INC.   522

TABLE 630         SONDE HEALTH, INC.: COMPANY OVERVIEW    522

TABLE 631         SONDE HEALTH, INC.: PRODUCT LAUNCHES    522

TABLE 632         SONDE HEALTH, INC.: DEALS   523

13.1.15  FUTURESTHRIVE           524

TABLE 633         FUTURESTHRIVE: COMPANY OVERVIEW           524

13.1.16  KONINKLIJKE PHILIPS N.V.        525

TABLE 634         KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW         525

FIGURE 43         KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)              526

TABLE 635         KONINKLIJKE PHILIPS N.V.: DEALS        527

13.1.17  ALPHABET INC. (FITBIT)            528

TABLE 636         ALPHABET INC.: COMPANY OVERVIEW 528

FIGURE 44         ALPHABET INC.: COMPANY SNAPSHOT (2022)  529

TABLE 637         ALPHABET INC.: PRODUCT LAUNCHES & APPROVALS  530

TABLE 638         ALPHABET INC.: DEALS 531

13.1.18  RESMED INC.    532

TABLE 639         RESMED INC.: COMPANY OVERVIEW     532

FIGURE 45         RESMED INC.: COMPANY SNAPSHOT (2023)       533

TABLE 640         RESMED INC.: PRODUCT LAUNCHES    534

TABLE 641         RESMED INC.: DEALS    534

13.1.19  APPLE INC.        535

TABLE 642         APPLE INC.: COMPANY OVERVIEW        535

FIGURE 46         APPLE INC.: COMPANY SNAPSHOT (2023)          536

TABLE 643         APPLE INC.: PRODUCT LAUNCHES        537

13.1.20  COGNITIVE HEALTH SOLUTIONS          538

TABLE 644         COGNITIVE HEALTH SOLUTIONS: COMPANY OVERVIEW              538

13.2       OTHER PLAYERS           539

13.2.1    WELLIN5 USA, INC.        539

13.2.2    MOODTOOLS   539

13.2.3    MOODFIT          540

13.2.4    COGNIABLE      540

13.2.5    WOEBOT LABS, INC.      541

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14          APPENDIX         542

14.1       DISCUSSION GUIDE      542

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             548

14.3       CUSTOMIZATION OPTIONS      550

14.4       RELATED REPORTS       550

14.5       AUTHOR DETAILS         551